FODMAPs (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, And Polyols) are short-chain carbohydrates that are poorly absorbed in the small intestine and rapidly fermented by gut bacteria. In health, they are fermented in the colon producing beneficial short-chain fatty acids; in SIBO or IBS, they cause symptoms through small intestinal fermentation.
FODMAPs are osmotically active, drawing water into the gut lumen, and rapidly fermented by bacteria producing gas (hydrogen, methane, CO2). Normally, fermentation occurs in the colon by symbionts (Bifidobacteria, Lactobacilli) producing SCFAs like butyrate. In SIBO, fermentation occurs prematurely in the small intestine, causing bloating, pain, and distension. The gas production and osmotic effects create mechanical distension that triggers visceral hypersensitivity in IBS patients.
FODMAP restriction has the best evidence for symptom control in IBS and IBD but is a therapeutic tool, not a long-term diet. Chronic diseases reduce beneficial bacteria populations (Bifidobacteria, butyrate-producers), so the outcome depends on nutritional intervention choice. Long-term FODMAP restriction risks reducing microbiome diversity and immune tolerance. The goal is symptom control during treatment, followed by gradual reintroduction to restore diversity.
- Acronym: Fermentable Oligosaccharides, Disaccharides, Monosaccharides, And Polyols
- Poorly absorbed in small intestine, rapidly fermented by bacteria
- Normally fermented in colon producing beneficial SCFAs
- In SIBO, fermentation occurs in small intestine causing symptoms
- Osmotically active, drawing water into gut lumen
- Best evidence for IBS and IBD symptom control
- Should be therapeutic tool, not chronic dietary restriction
- Long-term restriction reduces Bifidobacteria and butyrate-producing species
- Worsens symptoms when raw foods, fiber, FODMAP-rich foods increase gas in SIBO
- SIBO — FODMAPs ferment prematurely in small intestine in SIBO, causing symptoms
- IBS — FODMAP restriction has strongest evidence for IBS symptom control
- IBD — low-FODMAP diet can reduce symptoms in inflammatory bowel disease
- short-chain fatty acids — colonic FODMAP fermentation produces beneficial SCFAs like butyrate
- butyrate — healthy FODMAP fermentation in colon produces butyrate for colonocyte health
- Bifidobacteria — key beneficial bacteria that ferment FODMAPs; reduced by chronic restriction
- gut microbiome — FODMAP restriction alters microbiome composition and diversity
- gut dysbiosis — chronic FODMAP restriction can worsen dysbiosis by reducing beneficial species
- fiber — many high-fiber foods are FODMAP-rich; restriction reduces fiber intake
- fermentation — FODMAPs are by definition highly fermentable carbohydrates
- gas formation — FODMAP fermentation produces hydrogen, methane, and CO2 gas
- bloating — FODMAP-induced gas and osmotic effects cause bloating and distension
- Visceral Hypersensitivity — FODMAP-induced distension triggers pain in viscerally hypersensitive IBS patients
- immune tolerance — chronic FODMAP restriction may impair oral tolerance development
- microbiome diversity — long-term restriction reduces microbial diversity
- Lactobacillus — lactobacilli ferment certain FODMAPs; affected by dietary restriction
- colon — site of healthy FODMAP fermentation producing SCFAs
- small intestine — in SIBO, FODMAPs ferment here instead of colon, causing symptoms
- osmolarity — FODMAPs are osmotically active, drawing water into gut
- Nutrition — FODMAP restriction is a therapeutic nutritional intervention, not permanent diet